raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:79432

Oculocutaneous albinism type 2

Synonyms: OCA2

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

A form of oculocutaneous albinism characterized by variable hypopigmentation of the skin and hair, numerous characteristic ocular changes and misrouting of the optic nerves at the chiasm.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enOculocutaneous albinism type 2OCA2
frAlbinisme oculocutané type 2AOC2
deAlbinismus, okulokutaner, Typ 2= en
esAlbinismo oculocutáneo tipo 2= en
itAlbinismo oculocutaneo, tipo 2= en
nlOculocutaan albinisme type 2OCA-2 · OCA2
ptAlbinismo oculocutâneo tipo 2= en
plAlbinizm oczno-skórny typu 2= en
csOkulokutánní albinismus, typ 2= en
ukОкулокутанний альбінізм, тип 2= en
zh眼皮肤白化病2型= en
trOkülokutanöz albinizm tip 2= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM203200Evalidated
ICD-10E70.3NTBTattributedvalidated
ICD-11EC23.20NTBTindexvalidated
MONDO0008746Evalidated
MeSHC537730Evalidated
UMLSC0268495Evalidated
GARD4038Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
OCA2Disease-causing germline mutation(s) inAssessedHGNC:8101ENSG0000010404461140915q12-q13.1OCA2 melanosomal transmembrane protein
MC1RModifying germline mutation inAssessedHGNC:6929ENSG0000025883915555516q24.3melanocortin 1 receptor12876664[PMID]
5

Prevalence and incidence

5 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 100 0002.55 / 100 000WorldwideValue and classValidated[EXPERT]_20301410[PMID]
Point prevalence6-9 / 10 00058.34 / 100 000Specific populationValue and classValidated12469324[PMID]_ORPHANET_[EXPERT]
Point prevalence6-9 / 10 00071.43 / 100 000Tanzania, United Republic ofValue and classValidated3978567[PMID]
Point prevalence1-9 / 100 0002.78 / 100 000United StatesValue and classValidated2667743[PMID]
Point prevalence1-5 / 10 00048.52 / 100 000AfricaValue and classValidatedORPHANET_7887411[PMID]_3978567[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

24 annotations · validated 2021-01-11
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0000539Abnormality of refraction
HP:0007703Abnormality of retinal pigmentation
HP:0000635Blue irides
HP:0001480Freckling
HP:0001100Heterochromia iridis
HP:0005599Hypopigmentation of hair
HP:0001010Hypopigmentation of the skin
HP:0007750Hypoplasia of the fovea
HP:0007730Iris hypopigmentation
HP:0012805Iris transillumination defect
HP:0007988Macular hypopigmentation
HP:0000639Nystagmus
HP:0025551Optic nerve misrouting
HP:0000613Photophobia
HP:0007663Reduced visual acuity
HP:0002226White eyebrow
HP:0011364White hair
Occasional (29-5%)
HP:0200098Absent skin pigmentation
HP:0002671Basal cell carcinoma
HP:0012056Cutaneous melanoma
HP:0030856Posterior staphyloma
HP:0006739Squamous cell carcinoma of the skin
HP:0002227White eyelashes
Very rare (<4-1%)
HP:0007481Hyperpigmented nevi

Annotation source: 29050284[PMID]_26691042[PMID]_31199599[PMID]

7

Sources for this card